Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $172.06M.
ENTERPRISE VALUE (EV)
$172.06M
Jyong Biotech Ltd. Ordinary Shares
Market Cap
$154.72M
Enterprise Value (EV)
$172.06M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Jyong Biotech Ltd. Ordinary Shares (MENS) | $154.72M | $172.06M |
| LifeMD, Inc. (LFMDP)vs › | $154.79M | $135.66M |
| Neuronetics, Inc. (STIM)vs › | $155.32M | $222.65M |
| Inogen, Inc. (INGN)vs › | $157.61M | $86.12M |
| PepGen Inc. (PEPG)vs › | $158.83M | $152.16M |
| Cardiol Therapeutics Inc. (CRDL)vs › | $150.43M | $132.14M |
| Coherus Oncology, Inc. (CHRS)vs › | $159.14M | $113.92M |
| Minerva Neurosciences, Inc. (NERV)vs › | $160.27M | $135.61M |
| Codexis, Inc. (CDXS)vs › | $149.09M | $194.51M |
| Veraxa Biotech Holding AG (VRXA)vs › | $148.48M | N/A |
Market Cap
$154.72M
Total Debt
$18.52M
Cash
$1.18M
Enterprise Value
$172.06M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
